Previous 10 | Next 10 |
Protalix BioTherapeutics to Hold Third Quarter 2020 Financial Results and Business Update Conference Call on October 29, 2020 Company to host conference call and webcast at 8:30 a.m. EDT PR Newswire CARMIEL, Israel, Oct. 22, 2020 CARMIEL, Israel , Oct. 22, ...
The transition toward a more sustainable energy system presents opportunities for investors, which have both patient capital and the sophistication to understand and underwrite the opportunity set. Renewable energy investment, a combination of public and private capital, exceeded $200...
CARMIEL, Israel , Sept. 8, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® plant...
CARMIEL, Israel , Sept. 8, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® plant...
Investment Thesis It isn't your grandfather's energy landscape anymore. You know, the environment in which almost all energy consumption comes from fossil fuels like coal, petroleum, and natural gas, and any power generated by renewable sources had to be heavily subsidized by the governme...
CARMIEL, Israel ,, Aug. 24, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® pla...
CARMIEL, Israel , Aug. 11, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® plant...
CARMIEL, Israel , Aug. 10, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® ...
CARMIEL, Israel , Aug. 6, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® p...
CARMIEL, Israel , Aug. 3, 2020 /PRNewswire/Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® plant cell...
News, Short Squeeze, Breakout and More Instantly...
Invesco Global Clean Energy Company Name:
PBD Stock Symbol:
NYSE Market:
2024-06-09 04:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Protalix BioTherapeutics to Present at the 2024 BIO International Convention PR Newswire Corporate presentation scheduled for Monday, June 3, 2024 at 2:30 P.M. PDT CARMIEL, Israel , May 29, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc....
2024-05-28 12:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...